Solid Tumor

我们是谁

  • 2 月 7, 2024
    Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor
  • 1 月 9, 2024
    KN035 for dMMR/MSI-H Advanced Solid Tumors
  • 1 月 9, 2024
    Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
  • 1 月 5, 2024
    Study of TU2218 in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
  • 4 月 12, 2023
    Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
  • 4 月 5, 2022
    QUILT 3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
  • 4 月 5, 2022
    针对实体瘤患者的 ROBO1 特异性 CAR-NK 细胞临床研究
  • 4 月 5, 2022
    CR6086 联合 Balstilimab 治疗 pMMR-MSS 转移性结直肠癌患者的 Ib/IIa 期研究
  • 4 月 5, 2022
    伊帕塞替联合阿特珠单抗的试验
  • 4 月 5, 2022
    A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors